Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2026-02-21 @ 1:20 AM
Study NCT ID:
NCT03068767
Status:
COMPLETED
Last Update Posted:
2020-02-12
First Post:
2017-02-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Relationship Between Vitamin D and Hepatitis B Virus Replication
Sponsor:
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Organization:
Study Overview
Official Title:
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Status:
COMPLETED
Status Verified Date:
2020-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
149 HBV carriers with inadequate serum vitamin D levels were randomized to two groups: one is supplied with vitamin D and another without as controls. The markers of HBV replication were compared before and after treatment.
Detailed Description:
This is a randomized case-control trial. A total of 149 HBV carriers with inadequate vitamin D (\< 30 ng/mL) level were enrolled. They were randomly divided to two groups: one group receiving vitamin D supplement (1600 IU/day) for 2 months and another group as controls. The serum vitamin D, HBV DNA and qHBsAg levels were measured at baseline and after vitamin D supplement. Whether HBV DNA and qHBsAg have significant change after vitamin D supplement can be determined.
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: